Clinical Trial Update: A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Glargine, in People With Type 2 Diabetes Who Have Not Used Insulin Before [Phase 3]

View source ↗

Summary

Phase 3 head-to-head trial comparing a new long-acting insulin, insulin icodec, with insulin glargine in adults with type 2 diabetes who have not used insulin b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin Glargine (insulin glargine)
• Insulin Icodec (insulin icodec)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2025-06-12